Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opthea Ltd ADR (NQ: OPT )

2.150 +0.060 (+2.87%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 531
Open 2.160
Bid (Size) 2.150 (7)
Ask (Size) 2.260 (11)
Prev. Close 2.090
Today's Range 2.150 - 2.160
52wk Range 1.600 - 4.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
7 Growth Stocks to Buy to Outperform the Nasdaq Index
These seven high-growth stocks across various sectors have the potential to outperform the tech-heavy Nasdaq over the long-run. 
Via InvestorPlace

Performance

YTD
-28.09%
-28.09%
1 Month
+13.76%
+13.76%
3 Month
-39.61%
-39.61%
6 Month
-21.82%
-21.82%
1 Year
-33.33%
-33.33%

More News

Read More
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Opthea to Receive US$35M Commitment and Additional US$50M Funding
From Opthea Limited
Via GlobeNewswire
Opthea Receives A$8.8 million R&D Tax Incentive
From Opthea Limited
Via GlobeNewswire
Opthea to Present at the FLORetina 2023 Congress
From Opthea Limited
Via GlobeNewswire
Opthea to Present at the Jefferies 2023 London Healthcare Conference
From Opthea Limited
Via GlobeNewswire
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
From Opthea Limited
Via GlobeNewswire
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
From Opthea Limited
Via GlobeNewswire
Opthea to Participate at the 2023 Euretina Congress
From Opthea Limited
Via GlobeNewswire
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Opthea Limited
Via GlobeNewswire
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)
From Opthea Limited
Via GlobeNewswire
Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
From Opthea Limited
Via GlobeNewswire
Opthea to Present at the 2023 Ophthalmology Innovation Summit
From Opthea Limited
Via GlobeNewswire
Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
From Opthea Limited
Via GlobeNewswire
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
From Opthea Limited
Via GlobeNewswire
Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
From Opthea Limited
Via GlobeNewswire
Opthea to Present at the Jefferies 2023 Healthcare Conference
From Opthea Limited
Via GlobeNewswire
Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market
From Opthea Limited
Via GlobeNewswire
Opthea To Present at the JMP Securities Life Sciences Conference
From Opthea Limited
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.